Please login to the form below

Not currently logged in
Email:
Password:

Avril Lee joins Burson-Marsteller in global role

Based in the UK, she joins the firm as its deputy global healthcare practice chair

Avril LeeBurson-Marsteller (BM) has strengthened its healthcare capabilities with the addition of Avril Lee, who joins the global PR and coms agency as  deputy global healthcare practice chair.

Based in the UK, Lee - who moves to the firm on February 19 - will partner with global healthcare practice chair Helene Ellison to expand the firm’s healthcare representation.

Commenting on the new appointment, BM’s worldwide chair and chief executive officer Don Baer said: “Avril is going to make a big contribution to helping us serve the most important healthcare clients in key markets around the world.”

For the past two years Lee has been serving as managing director of MSLGroup’s UK and EMEA Health Practices, overseeing business that included portfolio communications for Allergan.

Prior to that, she spent two years with Luther Pendragon as a director leading the AbbVie Humira business, and serving on the agency's senior leadership team, and before that she spent a decade with Ketchum London.

Lee said: “I am excited to get started expanding Burson-Marsteller’s healthcare expertise around the globe.”

12th February 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics